UTI Statistics
Total Valuation
UTI has a market cap or net worth of $1.68 billion. The enterprise value is $1.81 billion.
| Market Cap | 1.68B |
| Enterprise Value | 1.81B |
Important Dates
The last earnings date was Wednesday, February 4, 2026, after market close.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 55.02 million shares outstanding. The number of shares has increased by 0.65% in one year.
| Current Share Class | 55.02M |
| Shares Outstanding | 55.02M |
| Shares Change (YoY) | +0.65% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 2.83% |
| Owned by Institutions (%) | 88.49% |
| Float | 49.49M |
Valuation Ratios
The trailing PE ratio is 31.82 and the forward PE ratio is 42.46. UTI's PEG ratio is 2.83.
| PE Ratio | 31.82 |
| Forward PE | 42.46 |
| PS Ratio | 1.97 |
| Forward PS | 1.80 |
| PB Ratio | 5.01 |
| P/TBV Ratio | 5.87 |
| P/FCF Ratio | 101.46 |
| P/OCF Ratio | 21.72 |
| PEG Ratio | 2.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.13, with an EV/FCF ratio of 109.09.
| EV / Earnings | 33.68 |
| EV / Sales | 2.11 |
| EV / EBITDA | 17.13 |
| EV / EBIT | 25.21 |
| EV / FCF | 109.09 |
Financial Position
The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.86.
| Current Ratio | 1.14 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | 1.76 |
| Debt / FCF | 17.47 |
| Interest Coverage | 14.54 |
Financial Efficiency
Return on equity (ROE) is 17.44% and return on invested capital (ROIC) is 11.73%.
| Return on Equity (ROE) | 17.44% |
| Return on Assets (ROA) | 5.65% |
| Return on Invested Capital (ROIC) | 11.73% |
| Return on Capital Employed (ROCE) | 11.64% |
| Weighted Average Cost of Capital (WACC) | 10.23% |
| Revenue Per Employee | $208,544 |
| Profits Per Employee | $13,096 |
| Employee Count | 4,100 |
| Asset Turnover | 1.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $19.27 million in taxes.
| Income Tax | 19.27M |
| Effective Tax Rate | 26.41% |
Stock Price Statistics
The stock price has increased by +4.94% in the last 52 weeks. The beta is 1.37, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | +4.94% |
| 50-Day Moving Average | 27.37 |
| 200-Day Moving Average | 29.66 |
| Relative Strength Index (RSI) | 60.63 |
| Average Volume (20 Days) | 832,315 |
Short Selling Information
The latest short interest is 2.44 million, so 4.43% of the outstanding shares have been sold short.
| Short Interest | 2.44M |
| Short Previous Month | 2.78M |
| Short % of Shares Out | 4.43% |
| Short % of Float | 4.93% |
| Short Ratio (days to cover) | 4.28 |
Income Statement
In the last 12 months, UTI had revenue of $855.03 million and earned $53.69 million in profits. Earnings per share was $0.96.
| Revenue | 855.03M |
| Gross Profit | 481.78M |
| Operating Income | 71.72M |
| Pretax Income | 72.96M |
| Net Income | 53.69M |
| EBITDA | 105.59M |
| EBIT | 71.72M |
| Earnings Per Share (EPS) | $0.96 |
Balance Sheet
The company has $163.17 million in cash and $289.57 million in debt, with a net cash position of -$126.40 million or -$2.30 per share.
| Cash & Cash Equivalents | 163.17M |
| Total Debt | 289.57M |
| Net Cash | -126.40M |
| Net Cash Per Share | -$2.30 |
| Equity (Book Value) | 335.91M |
| Book Value Per Share | 6.11 |
| Working Capital | 30.79M |
Cash Flow
In the last 12 months, operating cash flow was $77.45 million and capital expenditures -$60.88 million, giving a free cash flow of $16.58 million.
| Operating Cash Flow | 77.45M |
| Capital Expenditures | -60.88M |
| Free Cash Flow | 16.58M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 56.35%, with operating and profit margins of 8.39% and 6.28%.
| Gross Margin | 56.35% |
| Operating Margin | 8.39% |
| Pretax Margin | 8.53% |
| Profit Margin | 6.28% |
| EBITDA Margin | 12.35% |
| EBIT Margin | 8.39% |
| FCF Margin | 1.94% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.65% |
| Shareholder Yield | -0.65% |
| Earnings Yield | 3.19% |
| FCF Yield | 0.99% |
Analyst Forecast
The average price target for UTI is $37.50, which is 22.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.50 |
| Price Target Difference | 22.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.45 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.45 |
| Piotroski F-Score | 8 |